Bill > SB5781

This bill aims to restore public trust in health communications by requiring Washington state government agencies and local health departments to strictly adhere to Food and Drug Administration (FDA) labeling guidelines when promoting or discussing FDA-regulated products. The legislation was primarily motivated by concerns about COVID-19 pandemic communications, specifically alleging that government entities made promotional claims about interventions like vaccines and masks that went beyond FDA authorization terms. The bill defines key terms such as "FDA labeling" and "FDA-regulated products" and establishes comprehensive requirements for government communications, including that all promotional materials must: (1) comply exactly with FDA labeling conditions, (2) be universally true or include clear disclaimers about product limitations, and (3) not use funding to spread non-compliant information. The bill mandates that agencies develop internal review processes to ensure compliance, requires immediate correction of any violations, and establishes that employees who violate these guidelines can face disciplinary action up to termination. Additionally, the state auditor is tasked with investigating complaints and protecting complainants from retaliation. The underlying intent is to prevent potentially misleading health communications and rebuild public confidence in government health messaging by ensuring strict adherence to official FDA guidelines and authorization terms.

Health and Social Services

https://app.leg.wa.gov/billsummary?BillNumber=5781&Year=2025&Initiative=false